Camille Bedrosian

Camille Bedrosian

Chief Tech/Sci/R&D Officer at AMYLYX PHARMACEUTICALS, INC.

Net worth: 2 M $ as of 2024-03-30

71 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Camille L. Bedrosian, MD, is an Independent Director at Rhythm Pharmaceuticals, Inc., an Independent Director at Crinetics Pharmaceuticals, Inc., a Chief Medical Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc., a Member at American Society of Clinical Oncology, a Member at American Society of Hematology and a Member at American Society of Nephrology. She is on the Board of Directors at Rhythm Pharmaceuticals, Inc. and Crinetics Pharmaceuticals, Inc. Dr. Bedrosian was previously employed as a Chief Medical Officer & Senior Vice President by Alexion Pharmaceuticals, Inc., a Chief Medical Officer & Vice President by ARIAD Pharmaceuticals, Inc., a Senior Director-Oncology & Hematology by Genetics Institute, Inc., a Member by American Association for Cancer Research, a Member by American Association for the Advancement of Science, a Member by Duke Comprehensive Cancer Center, and an Assistant Professor by Duke University Medical Center. She received her undergraduate degree from Harvard University, a graduate degree from Massachusetts Institute of Technology and a doctorate degree from Harvard Medical School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-04-09 31,645 ( 0.04% ) 1 M $ 2024-03-30
2024-04-15 155,243 ( 0.23% ) 440 890 $ 2024-03-30
2023-06-15 6,000 ( 0.01% ) 280 860 $ 2024-03-30
2023-06-20 0 ( -.--% ) - $ 2024-03-30

Camille Bedrosian active positions

CompaniesPositionStart
CRINETICS PHARMACEUTICALS, INC. Director/Board Member 2020-09-02
RHYTHM PHARMACEUTICALS, INC. Director/Board Member 2020-12-08
AMYLYX PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2023-11-27
Corporate Officer/Principal -
Corporate Officer/Principal 2009-07-12
Corporate Officer/Principal 2009-07-12
Corporate Officer/Principal -
All active positions of Camille Bedrosian

Former positions of Camille Bedrosian

CompaniesPositionEnd
ULTRAGENYX PHARMACEUTICAL INC. Chief Tech/Sci/R&D Officer 2023-04-30
ALEXION PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2017-12-31
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
See the detail of Camille Bedrosian's experience

Training of Camille Bedrosian

Harvard University Undergraduate Degree
Massachusetts Institute of Technology Graduate Degree
Harvard Medical School Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Camille Bedrosian's experience

Connections

100 +

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
ULTRAGENYX PHARMACEUTICAL INC.

Health Technology

RHYTHM PHARMACEUTICALS, INC.

Health Technology

CRINETICS PHARMACEUTICALS, INC.

Health Technology

AMYLYX PHARMACEUTICALS, INC.

Health Technology

Private companies10

Health Technology

Health Technology

Health Technology

Health Services

Commercial Services

Commercial Services

Commercial Services

Health Services

Consumer Services

See company connections
  1. Stock Market
  2. Insiders
  3. Camille Bedrosian